Gastrodia elata ameliorates high-fructose diet-induced lipid metabolism and endothelial dysfunction

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Kho, Min Chul ^a   Lee, Yun Jung ^a   Cha, Jeong Dan ^b   Choi, Kyung Min ^b   Kang, Dae Gill ^a   Lee, Ho Sub ^a  

^a Wonkwang University   (South Korea)

^b Institute of Jinan Red Ginseng   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FRUCTOSE; GASTRODIA ELATA EXTRACT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBOHYDRATE DIET; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENZYME PHOSPHORYLATION; EPIDIDYMIS FAT; GASTRODIA ELATA; GLUCOSE BLOOD LEVEL; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; VASODILATATION;

EID: 84896452147     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/101624     Document Type: Article

References (33)

1. Egan B. M., Greene E. L., Goodfriend T. L., Insulin resistance and cardiovascular disease. The American Journal of Hypertension 2001 14 6 S116 S125 2-s2.0-0034981891
2. Grundy S. M., Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002 105 23 2696 2698 2-s2.0-0037062657 10.1161/01.CIR.0000020650. 86137.84 (Pubitemid 34615135)
3. Stanhope K. L., Havel P. J., Fructose consumption: recent results and their potential implications. Annals of the New York Academy of Sciences 2010 1190 15 24 2-s2.0-77950275577 10.1111/j.1749-6632.2009.05266.x
4. Basciano H., Federico L., Adeli K., Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition and Metabolism 2005 2, article 5 2-s2.0-15744394674 10.1186/1743-7075-2-5 (Pubitemid 40412656)
5. Kim H. Y., Okubo T., Juneja L. R., Yokozawa T., The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model. British Journal of Nutrition 2010 103 4 502 512 2-s2.0-77649210755 10.1017/S0007114509991978
6. Ouyang X., Cirillo P., Sautin Y., McCall S., Bruchette J. L., Diehl A. M., Johnson R. J., Abdelmalek M. F., Fructose consumption as a risk factor for non-alcoholic fatty liver disease. Journal of Hepatology 2008 48 6 993 999 2-s2.0-43049170503 10.1016/j.jhep.2008.02.011
7. Panchal S. K., Brown L., Rodent models for metabolic syndrome research. Journal of Biomedicine and Biotechnology 2011 2011 2-s2.0-79952213256 10.1155/2011/351982 351982
8. Ferder L., Ferder M. D., Inserra F., The role of high-fructose corn syrup in metabolic syndrome and hypertension. Current Hypertension Reports 2010 12 2 105 112 2-s2.0-77953534278 10.1007/s11906-010-0097-3
9. Tang W., Eisenbrand G., Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine 1992 Berlin, Germany Springer
10. Ding C.-S., Shen Y.-S., Li G., Wei Z., Wei F., Study of a glycoprotein from Gastrodia elata: its effects of anticoagulation and antithrombosis. Zhongguo Zhongyao Zazhi 2007 32 11 1060 1064 2-s2.0-34547615746
11. Musharof Hossain M., Therapeutic orchids: traditional uses and recent advances: an overview. Fitoterapia 2011 82 2 102 140 2-s2.0-79952362308 10.1016/j.fitote.2010.09.007
12. Ha J.-H., Shin S.-M., Lee S.-K., Kim J.-S., Shin U.-S., Huh K., Kim J.-A., Yong C.-S., Lee N.-J., Lee D.-U., In vitro effects of hydroxybenzaldehydes from Gastrodia elata and their analogues on GABAergic neurotransmission, and a structure-activity correlation. Planta Medica 2001 67 9 877 880 2-s2.0-0035676789 10.1055/s-2001-18844 (Pubitemid 34015559)
13. Lee Y. J., Hwang S. M., Kang D. G., Kim J. S., Lee H. S., Effect of Gastrodia elata on tumor necrosis factor-alpha-induced matrix metalloproteinase activity in endothelial cells. Journal of Natural Medicines 2009 63 4 463 467 2-s2.0-69949129813 10.1007/s11418-009-0352-6
14. Hwang S. M., Lee Y. J., Kang D. G., Lee H. S., Anti-inflammatory effect of Gastrodia elata rhizome in human umbilical vein endothelial cells. The American Journal of Chinese Medicine 2009 37 2 395 406 2-s2.0-65449137866 10.1142/S0192415X09006916
15. Tilg H., Hotamisligil G. S., Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006 131 3 934 945 2-s2.0-33748111665 10.1053/j.gastro.2006.05. 054 (Pubitemid 44307061)
16. Kelley G. L., Allan G., Azhar S., High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 2004 145 2 548 555 2-s2.0-0842291584 10.1210/en.2003-1167 (Pubitemid 38183796)
17. Miatello R., Vázquez M., Renna N., Cruzado M., Zumino A. P., Risler N., Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. The American Journal of Hypertension 2005 18 6 864 870 2-s2.0-19744369830 10.1016/j.amjhyper.2004.12.012 (Pubitemid 40745275)
18. Renna N. F., Vazquez M. A., Lama M. C., González E. S., Miatello R. M., Effect of chronic aspirin administration on an experimental model of metabolic syndrome. Clinical and Experimental Pharmacology and Physiology 2009 36 2 162 168 2-s2.0-58849114131 10.1111/j.1440-1681.2008.05042.x
19. Miller A., Adeli K., Dietary fructose and the metabolic syndrome. Current Opinion in Gastroenterology 2008 24 2 204 209 2-s2.0-40049101869 10.1097/MOG.0b013e3282f3f4c4 (Pubitemid 351322788)
20. Tran L. T., Yuen V. G., McNeill J. H., The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Molecular and Cellular Biochemistry 2009 332 1-2 145 159 2-s2.0-70450252198 10.1007/s11010-009-0184-4
21. Suzuki T., Hara H., Ingestion of guar gum hydrolysate, a soluble and fermentable nondigestible saccharide, improves glucose intolerance and prevents hypertriglyceridemia in rats fed fructose. Journal of Nutrition 2004 134 8 1942 1947 2-s2.0-3543083376 (Pubitemid 39031321)
22. Rexrode K. M., Manson J. E., Hennekens C. H., Obesity and cardiovascular disease. Current Opinion in Cardiology 1996 11 5 490 495 2-s2.0-0029767984 (Pubitemid 26320988)
23. Pepine C. J., Clinical implications of endothelial dysfunction. Clinical Cardiology 1998 21 11 795 799 2-s2.0-0031788902 (Pubitemid 28535739)
24. Tziomalos K., Athyros V. G., Karagiannis A., Mikhailidis D. P., Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutrition, Metabolism and Cardiovascular Diseases 2010 20 2 140 146 2-s2.0-75349088914 10.1016/j.numecd.2009.08.006
25. Chun X. Z., Xu X., Cui Y., Wang P., Wei X., Yang S., Edin M. L., Zeldin D. C., Dao W. W., Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats. Journal of Pharmacology and Experimental Therapeutics 2009 328 2 610 620 2-s2.0-59649114150 10.1124/jpet.108.143396
26. Mahmoud M. F., El-Nagar M., El-Bassossy H. M., Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats. Archives of Pharmacal Research 2012 35 1 155 162 2-s2.0-84856874824 10.1007/s12272-012-0117-8
27. Endemann D. H., Schiffrin E. L., Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Current Hypertension Reports 2004 6 2 85 89 2-s2.0-4644262824 (Pubitemid 39359547)
28. Lee W. J., In K. L., Hyoun S. K., Yun M. K., Eun H. K., Jong C. W., Sung M. H., Kim M.-S., Jo I., Goo T. O., Park I.-S., Jang H. Y., Park S.-W., Lee K.-U., Park J.-Y., -lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 12 2488 2494 2-s2.0-33644802810 10.1161/01.ATV.0000190667.33224.4c (Pubitemid 43732268)
29. Luo Z., Saha A. K., Xiang X., Ruderman N. B., AMPK, the metabolic syndrome and cancer. Trends in Pharmacological Sciences 2005 26 2 69 76 2-s2.0-12844281251 10.1016/j.tips.2004.12.011 (Pubitemid 40170168)
30. Majithiya J. B., Balaraman R., Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sciences 2006 78 22 2615 2624 2-s2.0-33646070557 10.1016/j.lfs.2005.10.020
31. Misra P., Chakrabarti R., The role of AMP kinase in diabetes. Indian Journal of Medical Research 2007 125 3 389 398 2-s2.0-34249313005 (Pubitemid 46805453)
32. Misra P., AMP activated protein kinase: a next generation target for total metabolic control. Expert Opinion on Therapeutic Targets 2008 12 1 91 100 2-s2.0-39049105534 10.1517/14728222.12.1.91 (Pubitemid 351247165)
33. Zhang Y., Lee T.-S., Kolb E. M., Sun K., Lu X., Sladek F. M., Kassab G. S., Garland T. Jr., Shyy J. Y.-J., AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 6 1281 1287 2-s2.0-33745038552 10.1161/01.ATV.0000221230.08596.98 (Pubitemid 44305371)